Ethically optimised designs.
1982; Wiley; Volume: 13; Issue: 4 Linguagem: Inglês
10.1111/j.1365-2125.1982.tb01407.x
ISSN1365-2125
Autores Tópico(s)Diabetes Management and Research
ResumoBritish Journal of Clinical PharmacologyVolume 13, Issue 4 p. 469-480 Free Access Ethically optimised designs. DG Clayton, DG ClaytonSearch for more papers by this author DG Clayton, DG ClaytonSearch for more papers by this author First published: April 1982 https://doi.org/10.1111/j.1365-2125.1982.tb01407.xCitations: 30AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat REFERENCES ALTMAN, D.G. (1980a). Statistics and ethics in medical research; misuse of statistics is unethical. Br. med. J., 2, 1182– 1184. ALTMAN, D.G. (1980b). Statistics and ethics in medical research VII-Interpreting results. Br. med. J., 2, 1612– 1614. ALTMAN, D.G. (1980c). Statistics and ethics in medical research; Study design. Br. med. J., 2, 1267– 1269. ARMITAGE, P. (1975). Sequential Medical Trials. Oxford: Blackwell Publications. BRITISH MEDICAL JOURNAL (1978). Leading article. Interpreting clinical trials. Br. med. J., 2, 1318. BURKHARDT, R. & KEINLE, G. (1978). Controlled clinical trials and medical ethics. Lancet, ii, 1356– 1359. COMMITTEE FOR THE ASSESSMENT OF THE BIOMETRIC ASPECTS OF CONTROLLED TRIALS OF HYPOGLYCAEMIC AGENTS (1975). J. Am. med. Ass., 231, 583– 608. DAY, N.E. (1969). A comparison of some sequential designs. Biometrika, 56, 301– 311. EDWARDS, A.W.F. (1972). Likelihood, Cambridge: Cambridge University Press. EUROPEAN CORONARY SURGERY STUDY GROUP (1979). Coronary artery by-pass surgery in stable angina pectoris: Survival at two years. Lancet, i, 889– 893. FOX, R.C. (1980). The Evolution of Medical Uncertainty. Milbank Memorial Fund Quarterly Health and Society, 58, 1– 49. FREIMAN, J.A., CHALMERS, T.C., SMITH, H. & KUEBLER, R.R. (1978). The importance of beta, the type II error and sample size in the design and interpretation of the randomised, controlled trial. New Engl. J. Med., 299, 690– 694. HILL, A.B. (1963). Medical ethics and controlled trials. Br. med. J., 1, 1043– 1049. KASS, L.R. (1979). ' Making babies' revised. The Public Interest (Winter), 32. LANCET (1979). Leading articles on controlled trials: Planned deception Lancet, i, 534– 535. LELLOUCH, J. & SCHWARTZ, D. (1971). L'essai therapeutique: ethique individuelle ou ethique collective Revue Inst. Int. Statist., 39, 127– 136. LINDLEY, D.V. (1973). Making decisions. London: Wiley. MAINLAND, D.M. (1960). The clinical trial—some difficulties and suggestions. J. chronic Dis., 11, 484– 496. POCOCK, P. (1980). Proceedings of European Symposium on Medical Statistics, Rome. REPORT FROM THE COMMITTEE OF PRINCIPAL INVESTIGATORS (1978). A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Br. Heart J., 60, 1069– 1118. SCHWARTZ, D., FLAMANT, R. & LELLOUCH, J. (1980). Clinical Trials, translated by M.J.R. Healy. London: Academic Press. SKEGG, D.C.G. & DOLL, R. (1977). The case for recording events in clinical trials. Br. med. J., 2, 1523– 1524. SIMON, R. (1977). Adaptive treatment assignment methods and clinical trials. Biometrics, 33, 743– 749. WALD, A. (1947). Sequential Analysis, New York: Wiley. WEINSTEIN, M.C. (1974). Allocation of subjects in medical experiments. New Engl. J. Med., 291, 1278– 1285. 18TH WORLD MEDICAL ASSEMBLY (1964). The Declaration of Helsinki. World Medical Journal. ZELLEN, M. (1969). Play the winner rule and the controlled clinical trial. J. Am. stat. Ass., 64, 131– 146. Citing Literature Volume13, Issue4April 1982Pages 469-480 ReferencesRelatedInformation
Referência(s)